A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2011
03/24/2011	US20110071127 Compounds Which Modulate the CB2 Receptor
03/24/2011	US20110071115 Pharmaceutically useful heterocycle-substituted lactams
03/24/2011	US20110071090 Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
03/24/2011	US20110070575 Immunomodulatory Compositions, Combinations and Methods
03/24/2011	US20110070294 Methods for the Administration of Drugs Using Liposomes
03/24/2011	US20110070292 Methods For The Preparation Of Liposomes
03/24/2011	US20110070290 Vaccine composition containing synthetic adjuvant
03/24/2011	US20110070270 Immunostimulating agent
03/24/2011	US20110070268 Method
03/24/2011	US20110070267 Packaged virus-like particles for use as adjuvants: method of preparation and use
03/24/2011	US20110070265 Engineered pertactin variants for vaccine use
03/24/2011	US20110070264 Rabies virus vector systems and compositions and methods thereof
03/24/2011	US20110070262 Viral Vectors and Their Use in Therapeutic Methods
03/24/2011	US20110070260 Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use
03/24/2011	US20110070259 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
03/24/2011	US20110070257 Polyvalent Chimeric OSPC Vaccinogen and Diagnostic Antigen
03/24/2011	US20110070256 Vaccine Antigens from Piscirickettsia Salmonis
03/24/2011	US20110070255 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
03/24/2011	US20110070254 Mutations in the influenza a virus ns1 gene and use thereof
03/24/2011	US20110070252 Mage-a3/hpv 16 peptide vaccines for head and neck cancer
03/24/2011	US20110070250 Therapeutical Composition Containing Dentritic Cells and use Thereof
03/24/2011	US20110070249 IMMUNIZING COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE AGAINST THE Beta-SECRETASE CLEAVAGE SITE OF AMYLOID PRECURSOR PROTEIN
03/24/2011	US20110070241 Methods for modulating immune responses to aav gene therapy vectors
03/24/2011	US20110070238 Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
03/24/2011	US20110070237 Methods of modulating and identifying agents that modulate intracellular calcium
03/24/2011	US20110070236 Use of immunesuppressant receptor
03/24/2011	US20110070234 Np1 activity regulating elements useful for the production of drugs for the treatment or prevention of human neurodegenerative diseases, resulting drugs and use thereof
03/24/2011	US20110070231 Stable liquid pharmaceutical formulation of igg antibodies
03/24/2011	US20110070230 Method and devices for identifying and treating a subject who has developed an anti-antibody response
03/24/2011	US20110070229 Method of selecting a monoclonal antibody for administration
03/24/2011	US20110070227 Treatment of Autoimmune and Inflammatory Diseases
03/24/2011	US20110070224 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
03/24/2011	US20110070220 Immunomodulating gene therapy
03/24/2011	US20110070213 Dermal compositions containing coenzyme q as the active ingredient
03/24/2011	US20110070191 T cell receptor fusions and conjugates and methods of use there of
03/24/2011	US20110070188 Bab triblock polymers having improved release characteristics
03/24/2011	US20110070162 Rna interference mediating small rna molecules
03/24/2011	US20110070159 Compositions comprising red microalgae polysaccharides and metals
03/24/2011	US20110070155 Anti-CD74 Immunoconjugates and Methods
03/24/2011	US20110070154 Artificial cells
03/24/2011	US20110070153 Artificial cells
03/24/2011	CA2774645A1 Pharmaceutical composition for peroral administration of 3,3'-diindolylmethane
03/24/2011	CA2774244A1 Treatment of autoimmune and inflammatory diseases with epratuzumab
03/24/2011	CA2773552A1 Treatment of neurological conditions
03/24/2011	CA2772689A1 Glycine compound
03/24/2011	CA2771176A1 Macrocyclic inhibitors of jak
03/23/2011	EP2298910A1 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof
03/23/2011	EP2298877A1 Compounds for immunotherapy of prostate cancer and methods for their use
03/23/2011	EP2298862A2 Mesenchymal stem cells and uses therefor
03/23/2011	EP2298860A2 Method of producing rough strains of bacteria and uses thereof
03/23/2011	EP2298815A1 B-cell reduction using CD37-specific and CD20-specific binding molecules
03/23/2011	EP2298808A1 Anti-C5 antibodies and their therapeutic uses
03/23/2011	EP2298803A2 Human G-protein coupled receptor and ligands thereof
03/23/2011	EP2298789A1 Mammalian genes; related reagents and methods
03/23/2011	EP2298769A1 Xanthin derivatives, their production and utilisation as medicine
03/23/2011	EP2298751A2 Polymorphs of ritonavir
03/23/2011	EP2298359A1 Nucleic acid capable of controlling degranulation of mast cell
03/23/2011	EP2298356A2 Multivalent VLA-4 antagonists comprising polymer moieties
03/23/2011	EP2298355A2 Albumin fusion proteins
03/23/2011	EP2298354A2 Remodelling and glycoconjugation of interferon-beta
03/23/2011	EP2298348A1 Antibody binding alpha4Beta7 integrin and its use to treat inflammatory bowel disease
03/23/2011	EP2298334A2 Tweak receptor
03/23/2011	EP2298333A2 Tweak receptor
03/23/2011	EP2298332A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response
03/23/2011	EP2298326A2 Administration of an anti-endotoxin drug by intravenous infusion
03/23/2011	EP2298308A2 Integrin-binding small molecules
03/23/2011	EP2298300A1 Compositions for inhibition of anglogenesis comprising thalidomide and aspirin
03/23/2011	EP2298299A2 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
03/23/2011	EP2298090A1 Pharmaceutical or nutraceutical composition
03/23/2011	EP2297204A2 Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells
03/23/2011	EP2297128A1 Inhibitors of ikk- serine-threonine protein kinase
03/23/2011	EP2297106A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
03/23/2011	EP2297105A1 Substituted amides, method of making, and use as btk inhibitors
03/23/2011	EP2296702A1 Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant
03/23/2011	EP2296684A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
03/23/2011	EP2296643A1 Nutritional composition for improving the mammalian immune system
03/23/2011	EP2195311B1 Pyridine derivatives as s1p1/edg1 receptor modulators
03/23/2011	EP1983990B1 A3 adenosine receptor allosteric modulators
03/23/2011	EP1552462B1 Methods of treating and preventing colitis involving il-13 and nk-t cells
03/23/2011	EP1448205B1 Combinations for the treatment of immunoinflammatory disorders
03/23/2011	EP1351707B1 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
03/23/2011	EP1285004B1 method of producing synthetic peptides
03/23/2011	EP1278748B1 Inhibitors of human phosphatidyl-inositol 3-kinase delta
03/23/2011	CN1922316B Mutants of anti-cd40 antibody
03/23/2011	CN1872155B Microspheres in use for injection of astragalus root and red sage root, and preparation method
03/23/2011	CN1840027B Chinese medicinal composite preparation with immunity-enhancing function
03/23/2011	CN101990547A Il-23 receptor antagonists and uses thereof
03/23/2011	CN101990541A Fused heteroaryl modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
03/23/2011	CN101990435A Selective agonist of toll-like receptor 3
03/23/2011	CN101987866A Staphylococcus aureus Efb protein C-end antigen epitope, as well as preparation method and usage thereof
03/23/2011	CN101987865A Antagonist of luteinizing hormone releasing hormone (LHRH) containing hydantoin structure
03/23/2011	CN101987847A Novel heterocyclic NF-kB inhibitors
03/23/2011	CN101987844A Method for synthesizing 4-(4-chlorobenzyl)-2-(hexahydro-1-methyl-1H-diazepoxide-4-radical)-1-(2H)-phthalizine hydrochloride
03/23/2011	CN101987162A Traditional Chinese medical preparation for treating anaphylatic purpura nephritis nephrotic syndrome
03/23/2011	CN101987114A Formulation of traditional Chinese medicinal herbal lotion for external use
03/23/2011	CN101987107A Immunemodulating oligosaccharides
03/23/2011	CN101623386B Medicine composition used for enhancing immunity and resisting fatigue
03/23/2011	CN101537034B Functional health care product containing maca and preparation method thereof
03/23/2011	CN101433669B Use of pharmaceutical composition in preparing medicament for preventing and treating allergic diseases
03/23/2011	CN101401820B Injection novel medicine for treating systematic lupus erythematosus

1 ... 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 ... 1172